REQUEST A DEMO
Total
USD $0.00
Search more companies

Zuellig Pharma Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Zuellig Pharma Pte. Ltd. Profile Updated: July 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Zuellig Pharma Pte. Ltd. is based in Singapore. The head office is in Singapore. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on June 14, 1990. It currently has a total number of 50 (estimated) employees. The company’s latest financial report indicates a net sales revenue increase of 8.79% in 2024. Over the same period, its total assets grew by 2.65%. The enterprise’s net profit margin decreased by 0.28% in 2024.

Headquarters
15 Changi North Way, #01-01, Singapore
Singapore; Singapore; Postal Code: 498770

Contact Details: Purchase the Zuellig Pharma Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Zuellig Pharma Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Zuellig Pharma Pte. Ltd. report to view the information.
Incorporation Date:
June 14, 1990
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Zuellig Pharma Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
8.79%
Total Operating Revenue
8.79%
Net Profit/Loss for the Period
-27.35%
Total Assets
2.65%
Total Equity
-30.34%
Net Profit Margin
-0.28%
Return on Equity (ROE)
1.85%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?